Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25840801 | 0.84 | SMN1; SMN2 (0.54) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL25840806 | 0.81 | RECQL (0.52) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL25840785 | 0.81 | NPC1 (0.60) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL25840791 | 0.80 | CA12 (0.46) | SMN1; SMN2MEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL23328399 | 0.80 | CDK1 (0.61) | SMN1; SMN2MEN1KMT2AHTTGAA | |
| SCHEMBL21319443 | 0.77 | SMN1; SMN2 (0.66) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL5455321 | 0.77 | SMN1; SMN2 (0.66) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL1276739 | 0.75 | KMT2A (0.79) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL25840772 | 0.75 | SMN1; SMN2 (0.58) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL25840794 | 0.75 | ABAT (0.72) | SMN1; SMN2MEN1KMT2ACYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | Kent Innovation & Enterprise (GB) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11701333-B2 | Antibacterial compounds | ARF1, ARL1, TLR1 | SMN1; SMN2 3087/4885MEN1 1300/4885KMT2A 2533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.